consequences of glp 1 long-term effects glp-1 medications Medications: Everything You Need to Know Adverse Effects of GLP-1 Receptor – The cardiovascular effects of GLP-1

[PMC free article: PMC11301120] [PubMed: 39109106] 9

& Chabrol, B

A 2.6% reduction in hip bone mineral density and a 2.1% reduction at the lumbar spine in 52 weeks (Hansen et al., 2024), combined with up to 10.9% lean mass loss over 72 weeks (Look et al., 2025), means that patients on GLP-1 therapy need a comprehensive musculoskeletal protection plan from day one

The following antibodies were used in this study: mouse monoclonal EBV ZEBRA antibody (sc-53904, Santa Cruz), rabbit polyclonal BRLF1 antibody (bs-45008, Bioss), mouse monoclonal GPX4 antibody (67763-1-Ig, Proteintech), rabbit polyclonal TNFR1 antibody (21574-1-AP